Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours Β· Estimated delivery Jul 28 - Aug 2
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
We are very comfortable with cortisone and stem cells because they have not been found to be performance enhancing drugs
It suffers from bioavailability issues, and the CNS-targeting theory remains unvalidated for this specific compound
And firms are still willing to bet on tauif its the right tau: Sanofi recently licensed for up to $1 billion an antibody that targets an acetylated form of the protein
BPC, I observe with so many patients, we're talking thousands upon thousands of patients, where their inflammation comes down so they feel better
US$ 20.70
US$ 28.51
US$ 22.75
US$ 21.98